Med Sci Pulse, cilt.16, sa.4, ss.66-73, 2022 (Hakemli Dergi)
Background: Survivors of Coronavirus Disease 2019 (COVID-19) pneumonia may have permanent loss o
lung function and radiological sequelae. There is a need for markers that predict patients for whom follow-up
is required.
Aim of the study: To identify the risk factors associated with post-COVID-19 radiological and functiona
findings.
Material and methods: This is a single-center retrospective study performed in a university hospital. We
obtained the data from all hospitalized patients with COVID-19 pneumonia. We included those who underwent pulmonary function tests (PFT) and chest computerized tomography (CT) 90-120 days later.
analyzed initial and peak laboratory results (C-reactive protein (CRP), d-dimer, ferritin, and fibrinogen), and
the length of hospital and intensive care unit (ICU) stay. We examined the relationship between baseline data
and radiological findings and PF
Results: Fifty-six patients were included in this study. Of these, 31 (55.4%) were women. The mean age of
the patients was 55.05±13.29 years. The mean peak ferritin, fibrinogen, d-dimer, and CRP values recorded
during hospitalization follow-up were 285.56±339.82, 518.59±186.93, 1.99±5.69, and 98.94±80.77, respectively. The mean length of hospital and ICU stay were 10.21±8.01 and 8.38±8.90 days, respectively. In 18
(32.1%) patients, we observed a restrictive pattern on PFT, and 22 (39.3%) patients had an abnormal diffusion test. In 21 (37.5%) patients we observed ground glass opacities and in 4 (7.1%) patients reticulatio
was seen on their chest CT. A multivariate logistic regression analysis revealed that the first visit and peak
fibrinogen values were significantly associated with abnormal PFT (p=0.049, R2=0.272), while ferritin a
CRP levels at the first visit and peak levels were significantly associated with an abnormality on chest
(p<0.001, p=0.05, respectively).
Conclusions: High initial and peak ferritin, fibrinogen, and CRP levels were associated with persistent radiological findings on chest CT and abnormal PFT at 90–120 days follow-up after COVID-19 pneum